BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2639725)

  • 1. Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia.
    Pirker R; Goldstein LJ; Ludwig H; Linkesch W; Lechner C; Gottesman MM; Pastan I
    Cancer Commun; 1989; 1(2):141-4. PubMed ID: 2639725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the multidrug resistance gene in myeloid leukemias.
    Sato H; Gottesman MM; Goldstein LJ; Pastan I; Block AM; Sandberg AA; Preisler HD
    Leuk Res; 1990; 14(1):11-21. PubMed ID: 2304354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis.
    Schultheis B; Wang L; Clark RE; Melo JV
    Leukemia; 2003 Oct; 17(10):2054-5. PubMed ID: 14513059
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis.
    Stagno F; Stella S; Berretta S; Massimino M; Antolino A; Giustolisi R; Messina A; Di Raimondo F; Vigneri P
    Leuk Res; 2008 Apr; 32(4):673-4. PubMed ID: 17889935
    [No Abstract]   [Full Text] [Related]  

  • 5. CEBPA mutation in a case of chronic myeloid leukemia presenting in myeloid blast crisis.
    Yin Y; Li J; Yan W; Cheng Z; Sun N; Zhang G
    Leuk Lymphoma; 2017 Mar; 58(3):708-710. PubMed ID: 27379703
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.
    Ahuja H; Bar-Eli M; Advani SH; Benchimol S; Cline MJ
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6783-7. PubMed ID: 2771957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoid blast crisis at the onset of chronic myelogenous leukaemia: molecular evidence.
    Roman J; Andres P; Jimenez MA; Torres A
    Br J Haematol; 1994 Jul; 87(3):624-6. PubMed ID: 7993807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plicamycin-hydroxyurea association in chronic granulocytic leukemia and multidrug resistance.
    Papineschi F; Carulli G; Petrini M
    Haematologica; 1991; 76(4):349. PubMed ID: 1686602
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of near-triploid with t(2;14)(p12;q32) in blast crisis of chronic myeloid leukemia detected by spectral karyotyping (SKY).
    de Oliveira FM; Scrideli CA; Tone LG
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):274-6. PubMed ID: 17414573
    [No Abstract]   [Full Text] [Related]  

  • 10. Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia.
    Oikawa H; Utsugisawa T; Murai K; Narigasawa Y; Miyairi Y; Shimosegawa K; Suzuki T; Kuriya S
    Int J Hematol; 1995 Jun; 61(4):229-30. PubMed ID: 8547613
    [No Abstract]   [Full Text] [Related]  

  • 11. Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph positive CML treated with alpha-interferon.
    Kawakubo K; Ohyashiki JH; Ohyashiki K; Tauchi T; Ohto T; Toyama K
    Cancer Genet Cytogenet; 1992 Feb; 58(2):165-8. PubMed ID: 1551082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregates of pseudo-Gaucher cells after treatment of chronic myeloid leukemia in blastic phase.
    Helbig G; Janikowska A; Kyrcz-Krzemien S
    Int J Hematol; 2015 Jan; 101(1):3-4. PubMed ID: 25380681
    [No Abstract]   [Full Text] [Related]  

  • 13. Prominent hematogone hyperplasia in BCR-ABL1-positive chronic myelogenous leukemia: mimicking recurrent B-lymphoid blast crisis.
    Horna P; Pantazopoulos P; Lancet JE; Moscinski LC; Zhang L
    Leuk Lymphoma; 2014 Aug; 55(8):1952-4. PubMed ID: 24304373
    [No Abstract]   [Full Text] [Related]  

  • 14. New variant translocation (8;20)(q22;q13) in bone marrow cells of extramedullary blast crisis in chronic myelogenous leukemia.
    Harada Y; Ishi K; Shirota T; Hayashi T
    Cancer Genet Cytogenet; 2000 Mar; 117(2):167-8. PubMed ID: 10704692
    [No Abstract]   [Full Text] [Related]  

  • 15. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic myelogenous leukemia with blastic crisis in which expression of P-glycoprotein was associated with resistance to chemotherapy].
    Utsunomiya A; Kuwazuru Y; Chuman Y; Mishige Y; Saito T; Terada A; Iwahashi M; Hanada S; Yoshimura A; Akiyama S
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1915-8. PubMed ID: 1355642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge.
    Nand S; Barton K
    Leuk Lymphoma; 2007 Feb; 48(2):215-6. PubMed ID: 17325875
    [No Abstract]   [Full Text] [Related]  

  • 18. Biclonal analysis of busulfan-induced sister chromatid exchange in blast crisis of Philadelphia chromosome-positive chronic myeloid leukemia.
    Becher R; Prescher G
    Cancer Genet Cytogenet; 1991 Mar; 52(1):71-8. PubMed ID: 2009513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful imatinib and arsenic trioxide combination therapy for sudden onset promyelocytic crisis with t(15;17) in chronic myeloid leukemia.
    Kashimura M; Ohyashiki K
    Leuk Res; 2010 Aug; 34(8):e213-4. PubMed ID: 20299093
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukaemia cells in blast crisis.
    Kuwazuru Y; Yoshimura A; Hanada S; Ichikawa M; Saito T; Uozumi K; Utsunomiya A; Arima T; Akiyama S
    Br J Haematol; 1990 Jan; 74(1):24-9. PubMed ID: 1968762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.